This topic contains a solution. Click here to go to the answer

Author Question: An infusion of 300 mg/250 mL is infusing at a rate of 38 mL/hr. Calculate the dose currently ... (Read 78 times)

mp14

  • Hero Member
  • *****
  • Posts: 534
An infusion of 300 mg/250 mL is infusing at a rate of 38 mL/hr. Calculate the dose currently infusing in mcg/min to the nearest whole number.
 
  What will be an ideal response?

Question 2

Order: D5  NS 240 ml IV at 10 ml/h to infuse over 24 hours. The initial flow rate was correctly set at 10 mcgtt/min. After eight hours, 220 ml of IV fluid remains to be infused. The infusion is behind schedule.
 
  Compute the new flow rate in gtt/min. so that the infusion will finish on time. Note that flow rates may not be adjusted by more than 25 of the original rate. To what rate would you reset the drip rate, or would you contact the prescriber instead? 1. Contact the prescriber.
  2. 13 gtt/min.
  3. 14 gtt/min.
  4. 9 gtt/min.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

emilymalinowski12

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

760 mcg/min

Answer to Question 2

1
Rationale 1:




mp14

  • Member
  • Posts: 534
Reply 2 on: Jul 3, 2018
Thanks for the timely response, appreciate it


Liamb2179

  • Member
  • Posts: 365
Reply 3 on: Yesterday
Excellent

 

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

For a complete list of videos, visit our video library